6 – 10 of 18
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod
(
- Contribution to journal › Article
- 2020
-
Mark
UTVÄRDERING AV SI-VERKSAMHETEN VID LUNDS UNIVERSITET 2019/20
2020)(
- Book/Report › Report
- 2016
-
Mark
Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosis
(
- Contribution to journal › Article
- 2015
-
Mark
Tasquinimod Modulates Suppressive Myeloid Cells and Enhances Cancer Immunotherapies in Murine Models
(
- Contribution to journal › Article
- 2013
-
Mark
The Tumor Targeted Superantigen ABR-217620 Selectively Engages TRBV7-9 and Exploits TCR-pMHC Affinity Mimicry in Mediating T Cell Cytotoxicity.
(
- Contribution to journal › Article